LLY

920.2

+0.28%↑

JNJ

235.65

-0.72%↓

ABBV

206.42

-0.47%↓

NVS

146.45

-1.15%↓

AZN

185.48

-1.36%↓

LLY

920.2

+0.28%↑

JNJ

235.65

-0.72%↓

ABBV

206.42

-0.47%↓

NVS

146.45

-1.15%↓

AZN

185.48

-1.36%↓

LLY

920.2

+0.28%↑

JNJ

235.65

-0.72%↓

ABBV

206.42

-0.47%↓

NVS

146.45

-1.15%↓

AZN

185.48

-1.36%↓

LLY

920.2

+0.28%↑

JNJ

235.65

-0.72%↓

ABBV

206.42

-0.47%↓

NVS

146.45

-1.15%↓

AZN

185.48

-1.36%↓

LLY

920.2

+0.28%↑

JNJ

235.65

-0.72%↓

ABBV

206.42

-0.47%↓

NVS

146.45

-1.15%↓

AZN

185.48

-1.36%↓

Home・Akcijų sąrašas・Pulse Biosciences Inc

Pulse Biosciences Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

21.97 -1.74

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

21.93

Max

23.12

Pagrindiniai rodikliai
By Trading Economics
Pajamos	2M -17M
Pardavimai	178K 264K
Pelnas, tenkantis vienai akcijai	-0.257
Pelno marža	-6,603.409
Darbuotojai	116
EBITDA	2M -17M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+33.27% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-07

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-179M 958M
Ankstesnė atidarymo kaina	23.71
Ankstesnė uždarymo kaina	21.97

Naujienos nuotaikos

By Acuity

25%

75%

39 / 350 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

16.59 / 17.17 Palaikymas ir pasipriešinimas

Pulse Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-19 18:34; UTC

Uždarbis

Canada to Allow Smaller Companies to Ax Quarterly Earnings Reports in Pilot

2026-03-19 17:43; UTC

Pagrindinės rinkos jėgos

Ecolab Dips on Report of Deal for CoolIT Systems With KKR

2026-03-19 23:47; UTC

Uždarbis

COSCO SHIPPING Holdings: Geopolitical Tensions Will Continue Driving Regional Fragmentation >1919.HK

2026-03-19 23:47; UTC

Uždarbis

COSCO SHIPPING Holdings: Container Shipping Market Saw Fluctuating, Declining Freight Rates >1919.HK

2026-03-19 23:47; UTC

Uždarbis

COSCO SHIPPING Holdings 2025 Rev CNY219.50B Vs. CNY233.86B >1919.HK

2026-03-19 23:47; UTC

Uždarbis

COSCO SHIPPING Holdings 2025 Net CNY30.86B Vs. Net CNY49.17B >1919.HK

2026-03-19 23:39; UTC

Uždarbis

Li Ning 2025 Net CNY2.94B Vs. Net CNY3.01B >2331.HK

2026-03-19 23:39; UTC

Uždarbis

Li Ning: Will Continue Targeting Consumer Needs, Strengthening User Engagement >2331.HK

2026-03-19 23:39; UTC

Uždarbis

Li Ning: Outdoor Category Continued Growing >2331.HK

2026-03-19 23:38; UTC

Uždarbis

Li Ning 2025 Rev CNY29.60B Vs. CNY28.68B >2331.HK

2026-03-19 23:33; UTC

Rinkos pokalbiai

Gold Edges Lower on Inflation Concerns, Dimmed Fed Rate-Cut Hopes -- Market Talk

2026-03-19 22:42; UTC

Įsigijimai, susijungimai, perėmimai

Unilever in Talks to Separate Food Business and Combine It With McCormick -- WSJ

2026-03-19 22:42; UTC

Įsigijimai, susijungimai, perėmimai

McCormick Has a Market Value of Around $14.8B -- WSJ

2026-03-19 22:42; UTC

Įsigijimai, susijungimai, perėmimai

Unilever in Talks to Combine Food Business With McCormick, Sources Say -- WSJ

2026-03-19 22:42; UTC

Įsigijimai, susijungimai, perėmimai

All-Stock Unilever-McCormick Deal Could Come Together Within Weeks, Sources Say -- WSJ

2026-03-19 22:23; UTC

Rinkos pokalbiai

FedEx Says It Can Raise Prices to Offset Higher Fuel Costs -- Market Talk

2026-03-19 22:09; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Australian Transport Stocks to Trade at Discount On Fuel Risks -- Market Talk

2026-03-19 22:06; UTC

Rinkos pokalbiai

Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk

2026-03-19 22:04; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

FedEx CFO: MD-11 Grounding Led to $120M Headwind to Adjusted Operating Income in 3Q

2026-03-19 22:03; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Energy Roundup: Market Talk

2026-03-19 22:03; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Fuel Prices, Scarcity Could Leave Mark on Australia's Gold Miners -- Market Talk

2026-03-19 21:51; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

FedEx CEO: InPost Deal Expected to Be Accretive to Earnings in Year One After Close

2026-03-19 20:57; UTC

Svarbiausios naujienos

Middle East Attacks, Inflation Fears Weigh on Stocks -- WSJ

2026-03-19 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-19 20:19; UTC

Svarbiausios naujienos

Brent Crude Retreats After Touching $119 -- WSJ

2026-03-19 19:49; UTC

Rinkos pokalbiai

Brent Crude Seen Potentially Rising to Top Its 2008 High -- Market Talk

2026-03-19 19:26; UTC

Svarbiausios naujienos

U.S. Consumers Face 'Global Oil Shock.' The Iran War Is Retail's Latest Challenge. -- Barrons.com

2026-03-19 19:10; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Natural Gas Rises in Volatile Trading -- Market Talk

2026-03-19 19:06; UTC

Svarbiausios naujienos

Brent Crude Prices Are Surging. Why Europe Is Facing an Energy Shock and the U.S. Isn't. -- Barrons.com

2026-03-19 18:08; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Silver Extends Slide to Seven Straight Sessions -- Market Talk

Akcijų palyginimas

Kainos pokytis

Pulse Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

33.27% į viršų

12 mėnesių prognozė

Vidutinis 30 USD 33.27%

Aukščiausias 30 USD

Žemiausias 30 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pulse Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

Pirkti

Laikyti

Parduoti

Remiantis 2 analitikų, pateikusių Pulse Biosciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

16.59 / 17.17Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Rinkos nuotaikos

By Acuity

39 / 350 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.